The 1 in 10 Physicians With Reservations about Vaccines could be Undermining the Fight Against COVID-19
There have been several cases of doctors expressing skepticism about vaccines in the media.
Do You Need a Second Booster Shot?
People ages 50 years and older and certain immunocompromised individuals who are at higher risk for severe disease, hospitalization and...
Long COVID Leaves Newly Disabled People Facing Old Barriers
Up to one-third of COVID-19 survivors will acquire the condition known as long or long-haul COVID-19.
How the ‘Test to Treat’ Initiative Aims to Get Ahead of the Next Wave of COVID-19
If a person tests positive and treatment is deemed appropriate, oral antiviral therapy can be prescribed on the spot at...
Repurposing Generic Drugs can Reduce Time and Cost to Develop New Treatments
Most of the time when drugs are repurposed for diseases or conditions they were not originally intended for, it is...
The cheerful lexicon of the Spanish language may help solve a health mystery called the Hispanic Paradox
This ability to minimize or exaggerate a situation by simply adding a suffix is one feature of the Spanish language...
Failure to Include Black Communities in Health Policy Public Engagement Perpetuates Health Disparities
The fact that the communities with the worst health outcomes are also the communities least likely to be meaningfully engaged...
Do We Really Know What a Million COVID-19 Deaths Mean?
For most people, visualizing what a million of anything looks like is an impossible task. The human brain just isn’t...
Tomorrow’s COVID Safety Guidelines Will be Different From Today’s
The constant back and forth of rules can be frustrating, but policy changes aren’t usually a sign of mistakes. Rather,...
The Human Genome Project Pieced Together Only 92% of the DNA – Now Scientists have Filled in the Remaining 8%
The first end-to-end human genome was officially published on Mar. 31, 2022.
How Does the COVID-19 Prevention Drug Evusheld Work?
Evusheld is the first FDA-authorized drug to prevent COVID-19 in high-risk people who aren’t adequately protected by vaccination alone.
Alopecia is No Laughing Matter for Millions of Black American Women
Alopecia is a medical word that refers to hair loss generally. And there are descriptors added which can refer to...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more